Case Study

Sandoz China: Do we stay or do we go?

12 pages
September 2025
Reference: IMD-2680

The Sandoz leadership team faced an important decision as it broke away from Novartis and became a public company. Should Sandoz retain the global geographical coverage it had had in its many years as part of Novartis? Or should it focus on fewer geographies and a simplification of the business models it was using? Since Sandoz was in a lower margin business than an innovator pharma company like Novartis, eventually, the senior leadership team decided to exit China. There was a belief that it was going to be difficult to compete on price with local Chinese companies, and the investment required to invest in more complex generics, as well as high-margin biosimilars, was beyond the means of Sandoz as it became a publicly listed company. The case also touches on the differences of opinion in a very strong leadership team and the options that were explored, or not, as the sale of Sandoz China to Aspen Pharmacare was concluded.

Learning Objective
  • Understand the extreme stress of a leadership team attempting to make myriad decisions in an unfavorable market environment.
  • Understand that strategy means choice – a company cannot do everything it wishes.
  • Evaluate an exit decision versus continued investment, considering both quantitative factors (market size, growth and profitability) and qualitative factors (strategic alignment, reputation and people impact).
  • Develop a sense of the differing opinions and objectives of the members of the leadership team and their ability to perform a multifaceted strategic analysis under uncertainty.
Keywords
Strategy, Pharmaceuticals, Mergers and Acquisitions
Settings
World/global
Sandoz, Healthcare, Pharmaceuticals
2023
Type
Field Research
Copyright
© 2025
Available Languages
English
Related material
Teaching note
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

IMD 中国- 概况 
Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics